View all veterinary jobs
The drug monographs in Part A were revised and updated by the Editorial Panel during 2025, and new monographs include citalopram, enflicoxib, ilunocitinib and verdinexor.
Part A also denotes drugs available as extemporaneous products, also called "veterinary specials", as VSP in the formulations section of the monographs.
Additional content in Part A includes information on drugs used for the management of urinary incontinence, while the Appendix now includes a seizure algorithm, guidance on supplements and nutraceuticals, and expanded information on contrast agents.
There are also 7 new client information leaflets in Part A, including bezafibrate, chloramphenicol, clomipramine and memantine.
Part B covers mammals, birds, reptiles, amphibians and fish, and its drug monographs were reviewed and updated by the Editorial Panel during 2025 under Editor-in-Chief Joanna Hedley.
New monographs in Part B include afoxolaner, atorvastatin and danofloxacin, and emergency drug doses for rabbits, rodents, ferrets, birds and reptiles have been added to the inside front cover.
Part B also adds Appendix information on barium and iodinated contrast agents for diagnostic imaging, and includes client information leaflets on inhaled medications, injectable medications, oral medications, topical ear medications and topical eye medications.
Additional information on proprietary fish medicines and drug doses for different species of British wildlife, including badgers, deer, foxes and hedgehogs, is available via the BSAVA library.
Eligible BSAVA members will receive a printed copy of Part A: Canine and Feline as part of their membership from April 2026 onwards, while all BSAVA members will have access to the online version via the BSAVA library and the BSAVA app from mid-April.
Printed copies are available for £37.70 for BSAVA members and £58.00 for non-members.
https://bsavaportal.bsava.com/s/store#/store/browse/cat/a0w8d000000Mh3FAAS/tiles